JP2004519450A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519450A5
JP2004519450A5 JP2002552911A JP2002552911A JP2004519450A5 JP 2004519450 A5 JP2004519450 A5 JP 2004519450A5 JP 2002552911 A JP2002552911 A JP 2002552911A JP 2002552911 A JP2002552911 A JP 2002552911A JP 2004519450 A5 JP2004519450 A5 JP 2004519450A5
Authority
JP
Japan
Prior art keywords
hal
carbon atoms
alkenyl
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002552911A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519450A (ja
JP4532071B2 (ja
Filing date
Publication date
Priority claimed from DE10064997A external-priority patent/DE10064997A1/de
Application filed filed Critical
Publication of JP2004519450A publication Critical patent/JP2004519450A/ja
Publication of JP2004519450A5 publication Critical patent/JP2004519450A5/ja
Application granted granted Critical
Publication of JP4532071B2 publication Critical patent/JP4532071B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002552911A 2000-12-23 2001-12-19 ベンゾイルピリダジン Expired - Fee Related JP4532071B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064997A DE10064997A1 (de) 2000-12-23 2000-12-23 Benzoylpyridazine
PCT/EP2001/015070 WO2002051814A1 (en) 2000-12-23 2001-12-19 Benzoylpyridazines

Publications (3)

Publication Number Publication Date
JP2004519450A JP2004519450A (ja) 2004-07-02
JP2004519450A5 true JP2004519450A5 (enExample) 2009-03-05
JP4532071B2 JP4532071B2 (ja) 2010-08-25

Family

ID=7668970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002552911A Expired - Fee Related JP4532071B2 (ja) 2000-12-23 2001-12-19 ベンゾイルピリダジン

Country Status (20)

Country Link
US (1) US7312328B2 (enExample)
EP (1) EP1343769B1 (enExample)
JP (1) JP4532071B2 (enExample)
KR (1) KR20030065564A (enExample)
CN (1) CN1483026A (enExample)
AR (1) AR032010A1 (enExample)
AT (1) ATE476423T1 (enExample)
BR (1) BR0116304A (enExample)
CA (1) CA2432568C (enExample)
CZ (1) CZ20031860A3 (enExample)
DE (2) DE10064997A1 (enExample)
ES (1) ES2349622T3 (enExample)
HU (1) HUP0302562A2 (enExample)
MX (1) MXPA03005494A (enExample)
NO (1) NO20032862L (enExample)
PL (1) PL364229A1 (enExample)
RU (1) RU2003122188A (enExample)
SK (1) SK8662003A3 (enExample)
WO (1) WO2002051814A1 (enExample)
ZA (1) ZA200305661B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
AR049384A1 (es) * 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
WO2010135468A1 (en) * 2009-05-19 2010-11-25 Vivia Biotech S.L. Methods for providing personalized medicine tests ex vivo for hematological neoplasms
US10806711B2 (en) 2011-08-12 2020-10-20 University Of Cincinnati Method of treating acute decompensated heart failure with probenecid
MX376077B (es) 2013-03-13 2025-03-07 Univ Cincinnati Tratamiento de una disfuncion cardiaca diastolica con un agonista del receptor trpv2.
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
CN105175283A (zh) * 2015-09-23 2015-12-23 蚌埠中实化学技术有限公司 一种3-乙氧基-4-甲氧基苯腈的制备方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE209189T1 (de) * 1992-07-01 2001-12-15 Ortho Pharma Corp 1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen
ATE260911T1 (de) 1993-12-22 2004-03-15 Celltech R&D Ltd Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
US5786354A (en) 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412672D0 (en) 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
GB9525262D0 (en) 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
DE19632549A1 (de) 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19826841A1 (de) * 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazine
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine

Similar Documents

Publication Publication Date Title
JP2003531118A5 (enExample)
JP2002332234A5 (enExample)
JP2006526031A5 (enExample)
JP2006151984A5 (enExample)
JP2004519450A5 (enExample)
JP2009504763A5 (enExample)
JP2002520316A5 (enExample)
JP2004537516A5 (enExample)
JP2006520339A5 (enExample)
JP2006515626A5 (enExample)
JP2006182786A5 (enExample)
JP2005522505A5 (enExample)
JP2004530641A5 (enExample)
JP2007505916A5 (enExample)
JP2002540208A5 (enExample)
JP2005511697A5 (enExample)
JP2004501940A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2003508534A5 (enExample)
JP2007537301A5 (enExample)
JP2004516329A5 (enExample)
JP2004529953A5 (enExample)
JP2002506864A5 (enExample)
JP2002520286A5 (enExample)
JP2002169296A5 (enExample)